The latest biotech news

News and Trends 11 Apr 2018

French CAR-T Developer Raises $164M Despite a Challenging Road

Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed results in the technology’s development up until now. Cellectis, based in Paris, has closed a follow-on offering on NASDAQ, raising a total of around $164M (€132M). The funding will be used to further continue clinical development […]

April 11, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 10 Apr 2018

Microbes Come to the Rescue to Reduce Hospital Waste

Hospital waste management is no laughing matter, given that one hospital bed can produce up to 0.5 kg of waste per day. A Dutch technology is using microbes to optimize the process with anaerobic digestion. We look to hospitals and our healthcare systems at large for treatment and reassurance when we are sick, but it […]

April 10, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 10 Apr 2018

New Skin Care Products Use Plant Pigment Made By Bacteria

Deinove is launching a new compound made from a plant pigment that could be used in anti-aging and make-up products. Deinove, based in Montpellier, is the first company to produce pure phytoene, an anti-aging cosmetic compound, through bacterial fermentation. The company plans to launch an anti-aging and cosmetic skin care product, Phyt-N-Resist, made from their […]

April 10, 2018 - 2 minutesmins - By Alexander Burik

OSE Immunotherapeutics Boehringer Ingelheim

News and Trends 5 Apr 2018

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has set its eyes on a new type of checkpoint inhibitor being developed by the French biotech. OSE Immunotherapeutics has entered a global license and collaboration deal with Boehringer Ingelheim for the development of OSE-172, a checkpoint inhibitor antibody to treat […]

April 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Apr 2018

First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US

Curetis is the first company to receive FDA approval to market a molecular diagnostic test for lung infections in the US. The test reduces the time taken to reach a diagnosis from several days under five hours. The FDA has given Curetis, a German biotech, the green light to launch its first-in-class Unyvero platform for diagnosing lung infections […]

April 4, 2018 - 3 minutesmins - By Alexander Burik

genesight gene therapy blindness placebo

News and Trends 4 Apr 2018

Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial

GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly improve the vision of patients. But so does the placebo. GenSight Biologics has released the results of a Phase III clinical trial testing its gene therapy GS010 in patients suffering from Leber hereditary optic neuropathy (LHON), a rare mitochondrial disease […]

April 4, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Cheese Producing Bacteria Could Help Treat Type 1 Diabetes

News and Trends 3 Apr 2018

Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes

ActoBio Therapeutics has received permission from the FDA to start a clinical trial for a type 1 diabetes treatment that uses a bacterial strain also used in cheese production. After being cleared by the FDA, ActoBio, based in Belgium, plans to begin a PhaseIb/IIa study for its drug, AG019, to treat early-onset type 1 diabetes. What makes […]

April 3, 2018 - 2 minutesmins - By Editorial Team

News and Trends 29 Mar 2018

Cancer Trial Halted in the UK After Overdosing First Patient

Redx Pharma has temporarily interrupted recruitment in a Phase I/IIa cancer trial following “significant adverse events” of its drug on the first patient treated. The first time Redx Pharma’s cancer drug RXC004 has been tested in a patient has resulted in adverse side effects. According to Redx, the dose tested resulted in a higher exposure […]

March 29, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Mar 2018

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is collaborating with Parkinson’s UK and The Cure Parkinson’s Trust (CPT), two UK charities, to repurpose at least three existing drugs and identify two novel drug targets […]

March 28, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 27 Mar 2018

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

Angle, a UK-based biotech, is developing a non-invasive liquid biopsy that could be better than current diagnostic methods at predicting ovarian cancer. Angle, a company specializing in liquid biopsies, has shown that its Pelvic Mass Triage (PMT) liquid biopsy test can differentiate between benign and cancerous pelvic masses and ovarian cysts in 95% of cases […]

March 27, 2018 - 2 minutesmins - By Alexander Burik

tigenix alofisel takeda stem cell therapy crohns disease

News and Trends 27 Mar 2018

Stem Cell Therapy for Crohn’s Disease Approved in Europe

Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved Alofisel (darvadstrocel), a stem cell therapy to treat complex perianal fistulas — one of the most disabling complications of Crohn’s disease. The cell therapy represents an alternative to multiple surgeries […]

March 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Allecra Therapeutics Urinary Tract Infections

News and Trends 26 Mar 2018

New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results

Allecra Therapeutics has obtained positive Phase II study results for its new urinary tract infection antibiotic, supporting the launch of a Phase III trial. Allecra Therapeutics, a French-German biotech, has obtained positive Phase II trial results for its lead antibiotic candidate for treating urinary tract infections. The drug, AAU101, was given to patients intravenously with cefepemine, another antibiotic […]

March 26, 2018 - 1 minutemin - By Alexander Burik

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

French CAR-T Developer Raises $164M Despite a Challenging Road

Microbes Come to the Rescue to Reduce Hospital Waste

New Skin Care Products Use Plant Pigment Made By Bacteria

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US

Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial

Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes

Cancer Trial Halted in the UK After Overdosing First Patient

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

Stem Cell Therapy for Crohn’s Disease Approved in Europe

New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!